Search This Blog

Wednesday, August 5, 2020

ACADIA Pharma EPS beats by $0.18, beats on revenue

August 5, 2020

ACADIA Pharma (NASDAQ:ACAD): Q2 GAAP EPS of -$0.27 beats by $0.18.
Revenue of $110.1M (+32.3% Y/Y) beats by $6.69M.
Shares +4%.
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)